STAT+: Kalshi comes for biopharma, with prediction markets for clinical trials and FDA approvals

Summary

Kalshi, a prediction market platform, is expanding into the biopharma industry to offer prediction markets for clinical trials and FDA approvals. The article announces this new market opportunity without providing specific details on implementation or partnerships.